Arypsa Stock

Arypsa Financial Leverage

The Financial Leverage (Equity Multiplier) of Arypsa (APYI) as of Aug 8, 2026 is 2.23.

Financial Leverage

2.23

Last updated:

Financial Leverage (Equity Multiplier) of Arypsa is 2026 2.23 . Financial Leverage (Equity Multiplier) of Arypsa was 2025 - . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Arypsa Stock analysis

What does Arypsa do? Aspyra Inc. is an American company based in California that specializes in the development and distribution of medical IT solutions. The history of Aspyra dates back to 1993 when the company was founded as an independent provider of medical imaging technology. In the following years, Aspyra expanded its business model and focused on developing integrated solutions for the healthcare industry. Today, the company offers a wide range of products and services such as RIS, PACS, LIS, and teleradiology systems that are used by hospitals, clinics, and medical practices worldwide. Aspyra also has specialized divisions within the company that focus on specific solutions. One of these divisions is INSIGHT, which specializes in the development of LIS systems. These solutions provide a specialized software platform that simplifies laboratory management and the workflow of medical tests and results. Another important division of Aspyra is the teleradiology department, which transmits specialized medical imaging findings and reports via telecommunication systems from one radiologist to another. This is particularly advantageous in providing care to patients in rural areas or areas with limited healthcare services. Aspyra also offers various software products, including the PACS system, the Radiology Information System (RIS), and the LIS system. The PACS system allows for the capture of medical images and provides them in electronic form, while the RIS system facilitates the management process of radiology departments and administrative processes related to the data. The LIS system, specifically tailored to the needs of laboratories, also supports the creation of contingency reports and better quality assurance. In recent years, Aspyra has also formed partnerships with other companies in the healthcare industry to expand its product portfolio. This includes a recent collaboration with Healthline Networks and First Databank to combine its IT systems with health data and information from third-party specialists. Aspyra has established itself as a leading provider of medical IT solutions and offers its customers a wide range of products and services. Thanks to its expertise in the healthcare industry, the company has been able to expand its presence in the global market and establish itself as an important partner for medical facilities in North America and Europe. Arypsa is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arypsa stock

Financial Leverage (Equity Multiplier) of Arypsa is 2.23 in 2026.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Arypsa since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Arypsa with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Arypsa

All Key Metrics — Arypsa